MAS Initiative for Tokenized Bank Liabilities & Regulated Stablecoins

1 min read

MAS launches initiative to enable settlement of tokenised bank liabilities, well-regulated stablecoins

Monetary Authority of Singapore Launches BLOOM Initiative

The Monetary Authority of Singapore (MAS) unveiled a pioneering initiative, known as BLOOM, on Thursday, October 16, aimed at enhancing the settlement capabilities provided by financial institutions. This initiative will see MAS collaborating with the financial sector to facilitate settlements using tokenized bank liabilities and well-regulated stablecoins through standardized methodologies.

Growing Interest in Tokenized Assets and Stablecoins

According to MAS, BLOOM is a response to the increasing enthusiasm from private-sector players regarding tokenized bank liabilities and stablecoins as viable settlement assets. Singaporean banks are progressively advancing their efforts in asset tokenization, which involves transforming tangible assets, like conventional deposits, into digital tokens recorded on a shared ledger. This innovative approach is anticipated to accelerate transaction processes and improve asset liquidity.

Stablecoin Market Projections

Stablecoins are gaining traction as well, representing cryptocurrencies designed to maintain a stable value in relation to specific assets, thereby reducing volatility compared to other digital currencies. JPMorgan projects that the current stablecoin market, valued at approximately $250 billion, is poised to expand two to threefold by the year 2028.

BLOOM Builds on Project Orchid

BLOOM is an extension of MAS’s previous endeavors under Project Orchid, which investigated potential applications for a digital Singapore dollar and the necessary infrastructure to support it. Since its inception in 2021, over ten trials have taken place under Project Orchid, with participating financial institutions converting their insights into commercially viable offerings. Notable examples include DBS’s development of a system for issuing conditional digital vouchers utilizing blockchain technology and smart contracts.

Enhanced Settlement Options

Kenneth Gay, MAS’s Chief Fintech Officer, emphasized that BLOOM advances the initiatives started under Project Orchid by broadening the range of settlement asset options available to participants. The BLOOM initiative includes various currencies, encompassing both G10 and Asian currencies, and addresses domestic and cross-border payment settlements, along with wholesale applications such as corporate treasury management, trade finance, and agentic payments.

Key Participants in the BLOOM Initiative

Among the members of this initiative are prominent local banks such as DBS, OCBC, and UOB, as well as international banks like Standard Chartered and JPMorgan. Additionally, cryptocurrency exchange Coinbase, XSGD issuer StraitsX, and USDC issuer Circle are part of the collaboration, along with Singapore investment firm Temasek.

Focus Areas for BLOOM

MAS outlined that the initial priorities for BLOOM will include the distribution and clearing of settlement assets, aiming to unify various networks and enable the smooth use, transfer, and redemption of diverse settlement asset forms. Another critical focus will be the implementation of programmable controls for standardized compliance checks, which MAS believes will lead to greater consistency in applications and reduced compliance costs.

Exploring Automated Payments

Lastly, BLOOM will investigate agentic payments, which involve the deployment of artificial intelligence agents that autonomously execute transactions under predefined limits and conditions. MAS noted that this approach aims to enhance cost efficiency by optimizing transfer timings when conditions are most advantageous and alleviating the demands of manual payment management.

Call for Collaboration

MAS expressed its eagerness to partner with additional financial institutions, industry collaborators, and regulatory bodies to advance the goals of BLOOM. Interested entities are encouraged to express their interest in collaboration or participation in trials.